Skip to main content

JACKSON SQUARE CAPITAL, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1812178 SAN FRANCISCO, CA

Position in GILD

as of Mar 31, 2026 · filed Apr 13, 2026
Position Value
$2,618,065
+$1,580,790 QoQ
Shares Held
18,785
+122.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

JACKSON SQUARE CAPITAL, LLC holds $34,281,243 across 7 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,618,065 18,785
2025-12-31 $1,037,275 8,451
2025-06-30 $759,459 6,850
2025-03-31 $897,632 8,011
2024-12-31 $207,740 2,249
2024-03-31 $1,039,564 14,192
2023-12-31 $1,160,792 14,329
2023-09-30 $1,069,993 14,278
2023-06-30 $1,051,234 13,640
2023-03-31 $1,115,199 13,441
2022-12-31 $1,138,027 13,256
2020-09-30 $54,343 860
2020-06-30 $66,168 860
2020-03-31 $64,293 860